15. _______ is the only disease modifying drug approved for progressive-relapsing MS 16. When c. Question
Answered step-by-step
Asked by studentsuccess420
15. _______ is the only disease modifying drug approved for progressive-relapsing MS
16. When caring for a patient receiving phenytoin, which assessment finding is a priority to report to the prescriber? (which of these findings represents a potentially dangerous outcome)
a. Excessive growth of gum tissue
b. Inadequate consumption of foods rich in calcium and vitamin D
c. Morbilliform-like rash
d. Continuous back and forth movements of the eyes
17. Generalized convulsive status epilepticus is considered a medical emergency and the first medication that should be administered because it will stop the seizures quickly is:
a. IV fosphenytoin
b. IV benzodiazepine like diazepam or lorazepam
c. an oral benzodiazepine like diazepam or lorazepam
d. oral phenytoin
18. Which of the following are mechanisms of action of antiepileptic drugs? (Select all that apply)
a. Inhibit the action of the neurotransmitter GABA
b. Impair influx of calcium in axon terminals to prevent transmitter release
c. Block the actions of glutamate at NMDA and AMPA receptor
d. Bind to sodium channels when they are in the inactive state
19. To prevent development of hypotension and bradycardia during IV administration of phenytoin, it should be administered no faster than 50 mg/minute. The patient has an order for a loading dose of 800 mg phenytoin IV. The nurse should infuse the medication over_____ minutes.
20. Patients who suffer from ______ have muscles that are continuously contracted and do not relax.
SCIENCE
HEALTH SCIENCE
NURSING
NURS MISC
15. _______ is the only disease modifying drug approved for progressive-relapsing MS 16. When c
